LYEL
Lyell Immunopharma, Inc.Company with tickers: LYEL
CIK
1806952
CUSIP
55083R203
Shares Outstanding
23,334,087
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-09 | Shah Smital | Director | Award | 140,000 |
| 2026-03-09 | Shah Smital | Director | Other | 0 |
| 2026-03-06 | ARCH Venture Partners IX, LLC | 10% Owner | Buy | 488,090 |
| 2026-03-06 | ARCH Venture Partners IX, LLC | 10% Owner | Other | 910,317 |
| 2026-03-06 | ARCH Venture Partners IX, LLC | 10% Owner | Other | 910,317 |
| 2026-03-06 | ARCH Venture Fund XIII, L.P. | 10% Owner | Other | 910,317 |
| 2026-03-06 | ARCH Venture Fund XIII, L.P. | 10% Owner | Other | 910,317 |
| 2026-03-06 | ARCH Venture Fund XIII, L.P. | 10% Owner | Buy | 488,090 |
| 2026-02-11 | Seely Lynn | Director, President and CEO | Sell | 7,455 |
| 2026-02-11 | Hill Stephen J. | Chief Operating Officer | Sell | 1,236 |
| 2026-02-11 | Lee Gary K. | Chief Scientific Officer | Sell | 1,671 |
| 2026-02-10 | Lee Gary K. | Chief Scientific Officer | Award | 50,000 |
| 2026-02-10 | Lee Gary K. | Chief Scientific Officer | Sell | 147 |
| 2026-02-10 | Seely Lynn | Director, President and CEO | Award | 155,000 |
| 2026-02-10 | Seely Lynn | Director, President and CEO | Sell | 438 |
| 2026-02-10 | Meltz Mark A | General Counsel | Award | 50,000 |
| 2026-02-10 | Shook David | Chief Medical Officer | Other | 21,900 |
| 2026-02-10 | Hill Stephen J. | Chief Operating Officer | Award | 65,000 |
| 2026-02-10 | Hill Stephen J. | Chief Operating Officer | Sell | 109 |
| 2026-02-10 | Bulis Veronica Sanchez | VP, Corporate Controller | Award | 8,750 |
| 2026-02-10 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 254 |
| 2026-02-10 | Shook David | Chief Medical Officer | Award | 50,000 |
| 2026-02-09 | Lee Gary K. | Chief Scientific Officer | Award | 4,000 |
| 2026-02-09 | Seely Lynn | Director, President and CEO | Award | 20,000 |
| 2026-02-09 | Hill Stephen J. | Chief Operating Officer | Award | 4,000 |
| 2025-12-30 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 936 |
| 2025-12-24 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 1,136 |
| 2025-11-10 | Hill Stephen J. | Chief Operating Officer | Sell | 95 |
| 2025-11-10 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell | 239 |
| 2025-11-10 | Seely Lynn | Director, President and CEO | Sell | 412 |
| 2025-11-10 | Lee Gary K. | Chief Scientific Officer | Sell | 138 |
| 2025-10-31 | Bulis Veronica Sanchez | VP, Corporate Controller | Other | 0 |
| 2025-10-31 | Bulis Veronica Sanchez | VP, Corporate Controller | Other | 9,452 |
| 2025-10-31 | Bulis Veronica Sanchez | VP, Corporate Controller | Other | 0 |
| 2025-10-31 | Bulis Veronica Sanchez | VP, Corporate Controller | Other | 0 |
| 2025-10-27 | Hill Stephen J. | Chief Operating Officer | Other | 15,845 |
| 2025-10-27 | Hill Stephen J. | Chief Operating Officer | Award | 75,000 |
| 2025-10-27 | Lee Gary K. | Chief Scientific Officer | Other | 15,504 |
| 2025-10-27 | Lee Gary K. | Chief Scientific Officer | Award | 68,000 |
| 2025-10-27 | Seely Lynn | Director, President and CEO | Award | 175,000 |
| 2025-10-27 | Seely Lynn | Director, President and CEO | Other | 67,571 |
| 2025-08-21 | Lee Gary K. | Chief Scientific Officer | Sell | 1,453 |
| 2025-08-21 | Seely Lynn | Director, President and CEO | Sell | 7,257 |
| 2025-08-21 | Hill Stephen J. | Chief Operating Officer | Sell | 1,004 |
| 2025-08-21 | Newton Charles W. | Director | Sell | 1,453 |
| 2025-08-20 | Lee Gary K. | Chief Scientific Officer | Award | 8,000 |
| 2025-08-20 | Seely Lynn | Director, President and CEO | Award | 40,000 |
| 2025-08-20 | Hill Stephen J. | Chief Operating Officer | Award | 8,000 |
| 2025-08-20 | Newton Charles W. | Director | Award | 8,000 |
| 2025-08-20 | Newton Charles W. | Director | Other | 10,000 |
| 2025-08-12 | Seely Lynn | Director, President and CEO | Sell | 406 |
| 2025-08-12 | Hill Stephen J. | Chief Operating Officer | Sell | 94 |
| 2025-08-12 | Lee Gary K. | Chief Scientific Officer | Sell | 136 |
| 2025-08-12 | Newton Charles W. | Director | Sell | 136 |
| 2025-08-11 | Seely Lynn | Director, President and CEO | Sell | 391 |
| 2025-08-11 | Hill Stephen J. | Chief Operating Officer | Sell | 91 |
| 2025-08-11 | Lee Gary K. | Chief Scientific Officer | Sell | 131 |
| 2025-08-11 | Newton Charles W. | Director | Other | 10,000 |
| 2025-08-11 | Newton Charles W. | Director | Sell | 131 |
| 2025-07-25 | ARCH Venture Partners IX, LLC | 10% Owner | Other | 910,317 |
| 2025-07-25 | ARCH Venture Partners IX, LLC | 10% Owner | Other | 910,317 |
| 2025-07-25 | ARCH Venture Fund XIII, L.P. | 10% Owner | Other | 938,438 |
| 2025-06-09 | Bachleda Mark | Chief Commercial Officer | Award | 13,000 |
| 2025-06-09 | Meltz Mark A | General Counsel | Award | 100,000 |
| 2025-06-09 | Shook David | Chief Medical Officer | Award | 43,750 |
| 2025-06-09 | Shook David | Chief Medical Officer | Award | 21,900 |
| 2025-06-09 | Bachleda Mark | Chief Commercial Officer | Other | 0 |
| 2025-06-09 | Shook David | Chief Medical Officer | Other | 0 |
| 2025-06-09 | Meltz Mark A | General Counsel | Other | 0 |
| 2025-05-15 | Ramachandra Sumant | Director | Award | 130,000 |
| 2025-05-15 | Klausner Richard | Director | Other | 2,967,834 |
| 2025-05-15 | Klausner Richard | Director | Award | 130,000 |
| 2025-05-15 | Klausner Richard | Director | Other | 843,365 |
| 2025-05-15 | RIEFLIN WILLIAM JL | Director | Award | 130,000 |
| 2025-05-15 | BRAWLEY OTIS W | Director | Award | 130,000 |
| 2025-05-15 | BRAWLEY OTIS W | Director | Other | 35,640 |
| 2025-05-15 | NABEL ELIZABETH G | Director | Award | 130,000 |
| 2025-05-15 | FRIEDMAN CATHY | Director | Other | 100,000 |
| 2025-05-15 | FRIEDMAN CATHY | Director | Other | 236,370 |
| 2025-05-15 | FRIEDMAN CATHY | Director | Award | 130,000 |
| 2025-05-15 | Ramachandra Sumant | Director | Other | 200,000 |
| 2025-03-31 | BRAWLEY OTIS W | Director | Buy | 35,640 |
| 2025-03-21 | Ramachandra Sumant | Director | Buy | 200,000 |
| 2025-03-17 | Newton Charles W. | Director | Buy | 200,000 |
| 2025-03-17 | Newton Charles W. | Director | Other | 172,725 |
| 2025-03-14 | Klausner Richard | Director | Other | 2,967,834 |
| 2025-03-14 | Klausner Richard | Director | Buy | 158,000 |
| 2025-03-14 | Seely Lynn | Director, President and CEO | Buy | 175,000 |
| 2025-02-10 | Hill Stephen J. | Chief Operating Officer | Award | 112,500 |
| 2025-02-10 | Hill Stephen J. | Chief Operating Officer | Award | 450,000 |
| 2025-02-10 | Hill Stephen J. | Chief Operating Officer | Award | 56,250 |
| 2025-02-10 | Newton Charles W. | Director | Award | 112,500 |
| 2025-02-10 | Newton Charles W. | Director | Award | 450,000 |
| 2025-02-10 | Newton Charles W. | Director | Award | 56,250 |
| 2025-02-10 | Lee Gary K. | Chief Scientific Officer | Award | 56,250 |
| 2025-02-10 | Lee Gary K. | Chief Scientific Officer | Award | 450,000 |
| 2025-02-10 | Lee Gary K. | Chief Scientific Officer | Award | 112,500 |
| 2025-02-10 | Seely Lynn | Director, President and CEO | Award | 1,350,000 |
| 2025-02-10 | Seely Lynn | Director, President and CEO | Award | 337,500 |
| 2025-02-10 | Seely Lynn | Director, President and CEO | Award | 168,750 |